Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
ChemMedChem(2)
2007 NSTI Nanotechnology Conference and Trade Show - NSTI Nanotech 2007, Technical Proceedings(1)
Expert Opinion on Drug Delivery(1)
Urologic Oncology: Seminars and Original Investigations(1)
Área temáticas
Farmacología y terapéutica(4)
Enfermedades(1)
Ingeniería civil(1)
Ingeniería y operaciones afines(1)
Medicina y salud(1)
Área de conocimiento
Cáncer(3)
Origen
scopus(5)
Co-delivery of hydrophobic and hydrophilic drugsfrom nanoparticle-aptamer bioconjugates
ArticleAbstract: (Figure Presented) Herein we report a novel targeted drug delivery system consisting of nanoparticlePalabras claves:Antitumor agents, conjugation, Dual drug delivery, Nanoparticles, Targeted therapyAutores:Bagalkot V., Basto P.A., Farokhzad O.C., Frank Alexis, Gu F.X., Jon S., Langer R.S., Radovic-Moreno A.F., Zhang L.Fuentes:scopusNew frontiers in nanotechnology for cancer treatment
ReviewAbstract: Nanotechnology is a field of research at the crossroads of biology, chemistry, physics, engineering,Palabras claves:Cancer diagnosis, cancer therapy, Nanocarriers, Targeting moleculesAutores:Farokhzad O.C., Frank Alexis, Langer R.S., Radovic-Moreno A.F., Rhee J.W., Richie J.Fuentes:scopusHER-2-targeted nanoparticle-affibody bioconjugates for cancer therapy
ArticleAbstract: (Figure Presented) Affibodies are a class of polypeptide ligand that are potential candidates for tiPalabras claves:Affibodies, Antitumor agents, Nanoparticles, PLA-PEG copolymers, Targeted therapyAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Levy-Nissenbaum E., Marein S.L., Molnar L.K., Pridgen E.M., Radovic-Moreno A.F., Wang A.Z., Westerhof K., Zhang L.Fuentes:scopusPolymeric nanoparticle drug delivery technologies for oral delivery applications
ReviewAbstract: Introduction: Many therapeutics are limited to parenteral administration. Oral administration is a dPalabras claves:chemotherapy, Inflammatory bowel disease, Insulin, M cells, mucoadhesives, mucosal vaccinations, oral delivery, Polymeric nanoparticles, transcytosisAutores:Farokhzad O.C., Frank Alexis, Pridgen E.M.Fuentes:scopusTargeted aptamer-nanoparticles to diminish drug resistance of cancer cells in vitro study
Conference ObjectAbstract: Using prostate cancer as a model, we report the drug release of Docetaxel and doxorubicin from aptamPalabras claves:aptamer, doxorubicin, Poly (D,L-lactic-co-glycolic acid) (PLGA), Prostate cancer, Targeted deliveryAutores:Basto P.A., Farokhzad O.C., Frank Alexis, Langer R.S., Zhang L.Fuentes:scopus